In pursuit of achieving data-driven excellence, PharmaShots came across Newstex. Soon, as a part of a collaboration PharmaShots and Newstex embarked on a journey to delivering high-quality and unerring content. Himanshu Sehgal, Director at PharmaShots, in a candid conversation with Newstex’s Head of Publisher Solutions, Laura Acosta. While sharing the origin story of PharmaShots, Himanshu…
Shots:
Following Qnovia’s recent partnership with the University of Virginia, Brian Quigley engages in a stimulating conversation with PharmaShots
The collaboration adds two assets, QN-05 for the treatment of pneumonia and QN-06 for the treatment of pulmonary infection caused by B. anthracis, to Qnovia’s portfolio
During a discussion of Qnovia's proprietary drug delivery platform RespiRx,…
Shots:
Betty Woo, VP of Cell, Gene, and Advanced Therapies, Thermo Fisher Scientific discusses the evolution of ThermoFisher’s strategic collaboration with ArsenalBio
Betty highlights the development of programmable autologous T cells for the treatment of cancer and the cell therapy collaboration program
Betty believes that through innovation and partnership, they can tap into the full…
Shots:
Ivy shared details of its collaboration with Intercept Pharmaceuticals and how Intercept is using Komodo’s tech platform and healthcare map for a retrospective real-world study on the long-term outcomes for Ocaliva
She also talked about how pharma companies can utilize Komodo’s technology platform and how it supports rare disease research
The interview gives an…
Shots:
Matthew spoke about Immunome’s collaboration and option agreement with AbbVie for the discovery of up to 10 novel antibody-target pairs arising from three specified tumor types using Immunome’s Discovery Engine
He also talked about how the partnership with AbbVie can support Immunome’s strategy to maximize the new drug discovery potential of its Discovery Engine…
Shots:
In continuation of our previous series on the top-performing drug of the month, based on 2021 revenue, this month we have selected Dupixent and prepared a curated analysis report for our readers
Dupixent is an interleukin-4 receptor alpha antagonist used for the treatment of multiple indications including atopic dermatitis, asthma, eosinophilic esophagitis, etc.
PharmaShots…
Shots:
Emily spoke about the launch of the new visual identity of Merz Aesthetics. The identity is built on the idea to create a cohesive and clear visual identity for Merz Aesthetics that reflects who they are and the purpose to fuel confidence
The brightness of this new identity includes shades of orange, yellow, green,…
Shots:
Josh spoke about the collaboration with MCI Onehealth. The collaboration will provide access to high-value data insights as a service for an array of research, clinical, and data science needs
Josh also talked about MDClone’s ADAMS platform which has a unique ability to convert datasets and cohorts of interest into synthetic files that are…
Shots:
Jeremiah spoke about Cionic’s recent collaboration with designer Yves Behar and his design firm, fuseproject to deliver its bionic leg wearable to determine human mobility in real-time
He talked about the results from the CIONIC trial and also discussed home usability trials to understand the impact of the Neural Sleeve on mobility over time…
Shots:
Dr.Chez talked about the challenges faced in epilepsy diagnosis and its various treatment options
Greg spoke about the new online series sponsored by Jazz Pharmaceuticals and how it benefits people with Epilepsy
The interview summarizes the vital role of caregivers in the lives of those living with epilepsy
Smriti: Can we talk about Epilepsy in…

